- Investing Ideas
- /
- Indian Net Cash Stocks With A Growth Track Record
Indian Net Cash Stocks With A Growth Track Record
UPDATED Apr 25, 2024
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
102 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
LICI | ₹988.05 | 1.5% | 79.7% | ₹6.2t | ₹1,088.83 | PE17.4x | E8.2% | 0.8% | Insurance | ||
500002 | ₹6,409.05 | 1.9% | 87.5% | ₹1.4t | ₹5,549.17 | PE108.8x | E14.9% | 0.4% | Capital Goods | ||
GICRE | ₹341.10 | 5.1% | 122.2% | ₹581.0b | ₹336.50 | PE8.8x | E-1.6% | 2.1% | Insurance | ||
LTTS | ₹4,778.10 | -8.7% | 26.6% | ₹548.1b | ₹4,806.46 | PE38.8x | E13.3% | 0.9% | Commercial Services | ||
505790 | ₹3,334.90 | 1.9% | 20.2% | ₹511.6b | ₹3,175.44 | PE58x | E12.7% | 0.8% | Capital Goods | ||
NAM-INDIA | ₹580.10 | 3.4% | 143.5% | ₹366.6b | ₹611.15 | PE33x | E8.6% | 2.8% | Diversified Financials | ||
500674 | ₹8,278.10 | 0.3% | 48.6% | ₹187.7b | ₹9,497.60 | PE31.6x | E9.2% | 2.0% | Pharmaceuticals & Biotech | ||
500252 | ₹16,679.40 | -1.2% | 56.1% | ₹178.8b | ₹12,809.00 | PE44.3x | E5.5% | 0.6% | Capital Goods | ||
500249 | ₹4,678.15 | 0.4% | 108.2% | ₹171.6b | ₹3,710.00 | PE78x | E29.5% | 0.4% | Capital Goods | ||
INDIAMART | ₹2,634.05 | 4.3% | -1.8% | ₹159.3b | ₹2,954.63 | PE54.4x | E21.3% | 0.4% | Capital Goods | ||
500405 | ₹689.10 | 7.2% | 80.1% | ₹132.9b | ₹558.50 | PE37.4x | E31.6% | 1.3% | Materials | ||
504067 | ₹621.00 | 7.9% | 123.5% | ₹130.4b | ₹639.50 | PE21.2x | E7.8% | 0.9% | Software | ||
505700 | ₹1,128.50 | -3.3% | 160.4% | ₹128.1b | n/a | PE35.6x | n/a | 0.4% | Capital Goods | ||
TANLA | ₹934.70 | 0.2% | 38.2% | ₹125.7b | ₹1,270.00 | PE22.9x | E15.5% | 1.1% | Software | ||
500265 | ₹890.30 | 2.8% | 105.5% | ₹121.3b | ₹1,230.00 | PE11.5x | E3.7% | 0.6% | Materials | ||
UTIAMC | ₹974.40 | 8.2% | 48.0% | ₹120.6b | ₹931.08 | PE16.2x | E-4.5% | 2.3% | Diversified Financials | ||
GLS | ₹814.95 | 1.5% | 61.6% | ₹92.0b | ₹852.00 | PE21.2x | E15.8% | 2.8% | Pharmaceuticals & Biotech | ||
520113 | ₹4,304.15 | 19.8% | 154.6% | ₹88.6b | ₹4,253.00 | PE41x | E13.5% | 0.3% | Capital Goods | ||
500123 | ₹10,907.20 | 11.8% | 105.2% | ₹79.3b | n/a | PE63x | n/a | 0.05% | Materials | ||
500126 | ₹4,724.40 | 0.6% | 1.5% | ₹78.4b | n/a | PE34.6x | n/a | 2.0% | Pharmaceuticals & Biotech | ||
505283 | ₹1,080.80 | 45.3% | 82.1% | ₹70.0b | ₹830.50 | PE52.5x | E27.7% | 0.5% | Capital Goods | ||
533553 | ₹349.90 | 20.5% | 101.2% | ₹53.8b | n/a | PE43.8x | n/a | 0.3% | Capital Goods | ||
SHANTIGEAR | ₹565.65 | 3.6% | 57.7% | ₹43.4b | n/a | PE57.1x | E18.3% | 0.9% | Capital Goods | ||
SWARAJENG | ₹2,479.05 | 1.8% | 42.6% | ₹30.1b | ₹2,469.00 | PE21.8x | E9.1% | 3.8% | Capital Goods |